Reversal of Drug Resistance in Human Breast Cancer - Hong, Lu;Li, Jianfeng
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

The powerful potential of usnic acid in overcoming cancer drug resistance takes center stage. Through meticulous laboratory studies and innovative experimental approaches, this book unveils how this natural compound, derived from Usnea barbata, demonstrates remarkable abilities in reversing multidrug resistance in breast cancer cells. The research particularly focuses on the MCF7/ADR cell line, offering detailed insights into cellular mechanisms and therapeutic applications. By combining traditional knowledge with cutting-edge scientific methodology, this comprehensive study explores usnic…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The powerful potential of usnic acid in overcoming cancer drug resistance takes center stage. Through meticulous laboratory studies and innovative experimental approaches, this book unveils how this natural compound, derived from Usnea barbata, demonstrates remarkable abilities in reversing multidrug resistance in breast cancer cells. The research particularly focuses on the MCF7/ADR cell line, offering detailed insights into cellular mechanisms and therapeutic applications. By combining traditional knowledge with cutting-edge scientific methodology, this comprehensive study explores usnic acid's cytotoxic activity, optimal dosage requirements, and its profound effects on cancer cell colonies. The work presents valuable findings for oncologists, pharmaceutical researchers, and medical professionals, offering new perspectives on combining natural compounds with conventional cancer treatments. This thorough investigation not only advances our understanding of drug resistance mechanisms but also opens new avenues for more effective cancer therapies, potentially revolutionizing how we approach treatment-resistant cancers in clinical settings.
Autorenporträt
Lu Hong is an assistant professor at Beijing City University, specializing in the reversal of drug resistance in human breast cancer. Her research focuses on understanding molecular mechanisms and developing novel therapeutic strategies. She has published several significant papers contributing to this field.